Literature DB >> 25641631

Vitamin D deficiency and acute vaso-occlusive complications in children with sickle cell disease.

Margaret T Lee1, Maureen Licursi, Donald J McMahon.   

Abstract

BACKGROUND: Vitamin D is increasingly recognized for its roles in non-skeletal disorders. Patients with sickle cell disease (SCD) have a high prevalence of vitamin D deficiency but data are limited with respect to possible associations between low vitamin D and acute vaso-occlusive complications. We examined whether vitamin D deficiency is associated with acute pain and acute chest syndrome (ACS) in children with SCD. PROCEDURE: A cross-sectional study was conducted in 95 children with SCD who had serum 25-hydroxyvitamin D (25-OHD) measured during comprehensive care examinations. History of acute pain and ACS within two years of obtaining 25-OHD was collected. Associations between 25-OHD levels and acute vaso-occlusive events were analyzed by logistic regression. Odds ratios and 95% confidence intervals were calculated for the risk of pain and ACS associated with vitamin D deficiency (25-OHD <20 ng/ml).
RESULTS: Subjects were 3-20 years old (median 10.6); 48 males, 47 females; 46 African, 49 Hispanic; 72 SS, 20 SC, 1 S/β(0) Thalassemia, and 2 S/β(+) Thalassemia. Median 25-OHD was 16 ng/ml. Fifty-six (59%) were vitamin D-deficient. Thirty-one (33%) and 29 (31%) had at least one episode of pain and ACS, respectively. Serum 25-OHD was significantly associated with pain (P = 0.0121) but not with ACS (P = 0.628). Of those with pain, 73% (23/31) were vitamin D-deficient while 26% (8/31) had 25-OHD ≥20 ng/ml (P = 0.04, OR = 2.7, 95%CI = 1.05-6.94).
CONCLUSIONS: Our findings emphasize the high prevalence of vitamin D deficiency and its potential association with acute pain in SCD. Correcting low vitamin D may offer a simple, low-cost intervention to help reduce acute vaso-occlusive complications.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute chest syndrome; pain; sickle cell disease; vitamin D

Mesh:

Substances:

Year:  2015        PMID: 25641631     DOI: 10.1002/pbc.25399

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  13 in total

Review 1.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Response to Long-term Vitamin D Therapy for Bone Disease in Children With Sickle Cell Disease.

Authors:  Kristen M Williams; Margaret T Lee; Maureen Licursi; Gary M Brittenham; Ilene Fennoy
Journal:  J Pediatr Hematol Oncol       Date:  2018-08       Impact factor: 1.289

3.  Vitamin D Deficiency and Its Association with Inflammatory Markers, Lipid Profile and Regulatory T-cells in Pediatric Sickle Cell Disease Patients.

Authors:  Yesim Oztas; Selma Unal; Gulcin Eskandari; Lulufer Tamer; Nuriman Ozgunes
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-13       Impact factor: 0.900

4.  Risk factors for vitamin D deficiency in sickle cell disease.

Authors:  Jin Han; Xu Zhang; Santosh L Saraf; Michel Gowhari; Robert E Molokie; Johara Hassan; Shivi Jain; Binal N Shah; Taimur Abbasi; Roberto F Machado; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2018-05-16       Impact factor: 6.998

5.  Vitamin D supplementation and pain-related emergency department visits in children with sickle cell disease.

Authors:  Anna M Hood; Charles T Quinn; Christopher D King; Lisa M Shook; James L Peugh; Lori E Crosby
Journal:  Complement Ther Med       Date:  2020-02-15       Impact factor: 2.446

Review 6.  Rheumatic Manifestations of Haemoglobinopathies.

Authors:  Michael Hughes
Journal:  Curr Rheumatol Rep       Date:  2018-08-14       Impact factor: 4.592

7.  Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease.

Authors:  Margaret T Lee; Meyer Kattan; Ilene Fennoy; Stephen M Arpadi; Rachel L Miller; Serge Cremers; Donald J McMahon; Jeri W Nieves; Gary M Brittenham
Journal:  Blood Adv       Date:  2018-05-08

8.  Influence of Nutrition on Disease Severity and Health-related Quality of Life in Adults with Sickle Cell Disease: A Prospective Study.

Authors:  Sanaa Kamal; Moheyeldeen Mohamed Naghib; Jamaan Al Zahrani; Huda Hassan; Karim Moawad; Omar Arrahman
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-01-01       Impact factor: 2.576

Review 9.  Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.

Authors:  Shahida Khan; Ashraf Ali; Sarah Khan; Ahmed Bakillah; Ghazi Damanhouri; Aziz Khan; Ahmad Makki; Ibtehal AlAnsari; Naheed Banu
Journal:  Nutr Metab (Lond)       Date:  2018-02-09       Impact factor: 4.169

10.  Vitamin D deficiency in sickle cell disease patients in the Eastern Province of Saudi Arabia.

Authors:  Ali AlJama; Mohammed AlKhalifah; Ibrahim Abdulla Al-Dabbous; Ghada Alqudaihi
Journal:  Ann Saudi Med       Date:  2018 Mar-Apr       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.